← Back
City Therapeutics
CTY · listed on Nasdaq · worth $1.11 billion
$22.14
+2.26% on Oct 29
Two insiders bought $6.12 million of City Therapeutics stock in the last two weeks. The biggest buyer was ARCH Venture Partners XII.
Different buyers at onceDirector Robert Nelsen bought, and 3 big investors reported new stakes, within 7 days · Oct 26
Green dot = an insider boughtA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
2.6M shares
5% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, two insiders bought City Therapeutics stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
10% owner
ARCH Venture Partners XII
Bought $3.06M on Oct 19 — 170,000 shares at $18.00, held through a trust or family, 1.2% of what they now own.
0 of 2 earlier purchases did better than the S&P 500
10% owner
Robert Nelsen
Bought $3.06M on Oct 19 — 170,000 shares at $18.00, held through a trust or family, 1.2% of what they now own.
0 of 1 earlier purchase did better than the S&P 500
Big investors
People and funds that reported owning 5% or more of City Therapeutics, newest first.
Filed by someone who owns 5% or more and may try to influence how the company is run.ARCH Venture Fund XII25.6%Oct 26
Filed by someone who owns 5% or more and does not plan to influence the company.Viking Global Investors LP7.0%Oct 26
Filed by someone who owns 5% or more and does not plan to influence the company.Invus Global Management8.1%Oct 22
All reports
Every insider trade and SEC report we hold for City Therapeutics.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Oct 19BoughtARCH Venture Partners XIIOct 19 · 10% owner+1.2%via a trust or family170,000 @ $18.00$3.06M